BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2
530 results:

  • 1. B-cell lymphoma with cytokine storm in serosal effusion: A case report and literature review.
    Zhang X; Shi X; Liu X; Li C; Xu Z; Dai X; Ma B; Zhu X
    Medicine (Baltimore); 2024 Mar; 103(10):e37400. PubMed ID: 38457551
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Serum interleukin-33 and soluble suppression of tumorigenicity 2 in pediatric leukemia with febrile neutropenia.
    Polat MC; Sönmez Ç; Yarali N; Özbek NY
    Eur J Pediatr; 2024 May; 183(5):2155-2162. PubMed ID: 38367066
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Misleading FDG Uptake in Oncology Assessment: Beyond COVID-19 Vaccination-The Role of Pneumococcal Vaccination.
    Moreau A; Mognetti T; Kryza D
    Clin Nucl Med; 2024 Mar; 49(3):283-284. PubMed ID: 38306382
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update.
    Roskoski R
    Pharmacol Res; 2024 Feb; 200():107059. PubMed ID: 38216005
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer Patients.
    Candal-Pedreira C; Ruano-Ravina A; Calvo de Juan V; Cobo M; Trigo JM; Rodríguez-Abreu D; Estival A; Carcereny E; Cucurull M; López Castro R; Medina A; García Campelo R; Cordeiro González P; Sánchez-Gastaldo A; Bosch-Barrera J; Massutí B; Dómine M; Camps C; Ortega AL; Sánchez-Hernández A; Guirado Risueño M; Del Barco Morillo E; Garrido Fernández A; Provencio M
    Arch Bronconeumol; 2024 Feb; 60(2):88-94. PubMed ID: 38160163
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The potential role of Epstein-Barr Virus in breast cancer development.
    Gouadfel K; Khenchouche A; Rabea S; Mansour AA; Salem-Bekhit MM; Ouhida S; Msela A; Salem MM; Erto A; Benguerba Y; Houali K
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(13):241-249. PubMed ID: 38158663
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Quality and Quantity of Nucleic Acids Extracted from Formalin-Fixed Paraffin-Embedded lymphoma Biopsies from Nigerian Archived Biopsy.
    Uzoma IC; Taiwo IA; Ugwu NI; Durosinmi MA; Akinloye O
    Niger J Clin Pract; 2023 Dec; 26(12):1854-1860. PubMed ID: 38158353
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Elevated serum IL-6 and total IgEAb are associated with poor survival in natural killer/T-cell lymphoma.
    Hui Y; Gao Y; Li J; Kong Q; Duan Y; Liu H; Liu F; Sang H
    Ann Hematol; 2024 Apr; 103(4):1285-1292. PubMed ID: 38095656
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review.
    Fulton-Ward T; Middleton G
    Ann Oncol; 2023 Dec; 34(12):1113-1130. PubMed ID: 37875224
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Systematic characterization of antibody-drug conjugate targets in central nervous system tumors.
    Coy S; Lee JS; Chan SJ; Woo T; Jones J; Alexandrescu S; Wen PY; Sorger PK; Ligon KL; Santagata S
    Neuro Oncol; 2024 Mar; 26(3):458-472. PubMed ID: 37870091
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial.
    Luke JJ; Patel MR; Blumenschein GR; Hamilton E; Chmielowski B; Ulahannan SV; Connolly RM; Santa-Maria CA; Wang J; Bahadur SW; Weickhardt A; Asch AS; Mallesara G; Clingan P; Dlugosz-Danecka M; Tomaszewska-Kiecana M; Pylypenko H; Hamad N; Kindler HL; Sumrow BJ; Kaminker P; Chen FZ; Zhang X; Shah K; Smith DH; De Costa A; Li J; Li H; Sun J; Moore PA
    Nat Med; 2023 Nov; 29(11):2814-2824. PubMed ID: 37857711
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Journey of CAR T‑cells: Emphasising the concepts and advancements in breast cancer (Review).
    Kausar MA; Anwar S; El-Horany HE; Khan FH; Tyagi N; Najm MZ; Sadaf ; Eisa AA; Dhara C; Gantayat S
    Int J Oncol; 2023 Dec; 63(6):. PubMed ID: 37830150
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Antibody drug conjugates (ADC) and bispecific antibodies in oncology - report of the 2022 Saint Louis day].
    Ranchon F; Chatelut É; Lambert J; Sesques P; Thibault C; Madelaine I; Rioufol C; Diéras V; Cazin JL
    Bull Cancer; 2023 Dec; 110(12):1343-1351. PubMed ID: 37827964
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The clinical characteristics and prognosis of patients with SAPHO syndrome--a real-world cohort study.
    Duan H; Gao S; Zhang L; Song L; Zhai J; Deng X
    Clin Rheumatol; 2024 Jan; 43(1):561-568. PubMed ID: 37755548
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. SMAD3, Cell proliferation and lymph nodes metastasis in breast cancer hormone-dependent.
    Oueslati M; Sassi N; Bettaieb I; Gamoudi A; Rahal K; Oueslati R
    Tunis Med; 2023 Feb; 101(2):273-279. PubMed ID: 37682272
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Unraveling the Mystery: Next Generation Sequencing Sheds Light on neuroblastoma Pathogenesis and Targeted Therapies.
    Aktas T; Kızmazoglu D; Aktas S; Erol A; Serinan E; Gokbayrak O; Ozdemir SM; Altun Z; Ozer E; Cecen E; Ince D; Olgun N
    Front Biosci (Landmark Ed); 2023 Aug; 28(8):171. PubMed ID: 37664946
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Multi-Phenotypic Breast Cancer Post-Radiotherapy for Hodgkin lymphoma: A Case of Secondary Malignancy.
    White D; Sadough Shahmirzadi M; Boulmay B
    J Investig Med High Impact Case Rep; 2023; 11():23247096231188251. PubMed ID: 37480256
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insights.
    Shibata T; Nohara S; Morikawa N; Shibao K; Ito S; Shibata R; Toh U; Nagafuji K; Fukami K; Fukumoto Y
    Eur J Prev Cardiol; 2023 Dec; 30(18):1941-1949. PubMed ID: 37352112
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The Implication of microRNAs as non-invasive biomarkers in 179 Egyptian breast cancer female patients.
    Shaaban NZ; Ibrahim NK; Saada HN; El-Rashidy FH; Shaaban HM; Elbakary NM; Kodous AS
    Oncol Res; 2022; 30(6):269-276. PubMed ID: 37303494
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment.
    Liu S; Xie SM; Liu W; Gagea M; Hanker AB; Nguyen N; Singareeka Raghavendra A; Yang-Kolodji G; Chu F; Neelapu SS; Marchese A; Hanash S; Zimmermann J; Arteaga CL; Tripathy D
    Breast Cancer Res; 2023 Jun; 25(1):62. PubMed ID: 37280713
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 27.